Canadian pharma company says it remains well positioned to meet its obligations
Pharmaceutical giant faces a growing list of questions from investors and regulators
Company has appointed activist investor William Ackman to its board
The Canadian drugmaker cut its 2016 forecast by about 12% causing shares to plunge
Deb Jorn oversaw the Canadian pharmaceutical’s US dermatology business
News comes as Canadian drug-maker pulled 2016 forecasts
Chief executive back at the helm after two-month absence through illness but Robert Ingram retains chairman’s post
Wall Street Journal reports that pharmaceutical firm plans to restate earnings
Pershing Square Capital increased stake in beleaguered drug group last November but acts to generate tax loss for investors
Eye-popping growth and questionable acquisitions raise far too many questions
Fast-growing company loses CFO Howard Schiller as it looks to address issues with $11bn Salix Pharma acquisition
Allergan employs about 900 here, most at its manufacturing plant in Westport
Pharmaceutical firm’s offer values the Botox maker at $53bn
YOU MAY ALSO LIKE...
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices